MedTrace Logo

Third Trimester Screening of Fetal Growth Restriction

NCT05787054 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 813

Last updated 2025-04-30

Study results available
· View outcomes & findings →

Summary

The aim of this trial is to assess the efficacy of two screening protocols for the detection of fetal growth disorders.

In Italy at the moment the screening protocol should not be universal but only on clinical indications. In some Regions the screening is offered to every pregnant women with an early third trimester scan at 28-32 weeks'gestation or, in other Regions, according to the new national recommandations, a growth scan during the third trimester is provided only if there is a clinical indication.

Conditions

  • Fetal Growth Retardation
  • Fetal; Slow Growth

Interventions

OTHER

Third trimester ultrasound

Single scan versus Longitudinal scan

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Alessandra Familiari, MD · Catholic University of the Sacred Heart, Rome

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2023-03-01
Completion
2023-05-27

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05787054 on ClinicalTrials.gov